Matthew Parker

Dr Matthew Parker is a Clinical Senior Lecturer at the Central Clinical School of the University of Sydney's Sydney Medical School and serves as Head of the Department of Rheumatology at Royal Prince Alfred Hospital. His clinical and research focus centers on autoimmune muscle diseases, connective tissue disease-associated interstitial lung disease (CTD-ILD), and myositis. He holds leadership roles in clinical care and research, including directing the Australian Myositis Registry and contributing to national guidelines for CTD-ILD management.

Dr. Parker's research spans biomarker discovery (e.g., VCAM-1 in systemic sclerosis prognosis), novel diagnostic techniques (smartphone-based capillaroscopy), and epidemiological studies on myositis incidence. He has published extensively in rheumatology and pulmonology, with over 30 peer-reviewed articles and book chapters. His work has been recognized with awards including the 2023 Australian Rheumatology Association New Investigator Award and the Brian Eaton Memorial PhD Scholarship (2020-2023).

Key contributions include advancing ILD classification criteria, validating nailfold capillaroscopy methods, and investigating immunosuppressive therapies for autoimmune myocarditis. He collaborates with multidisciplinary teams on projects such as the Australasian Interstitial Lung Disease Registry and the Australian Myositis Registry, emphasizing translational research to improve patient outcomes.